data_1j4w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j4w _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.379 -1.488 . . . . 2.04 109.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.434 ' H ' ' HG ' ' A' ' 2' ' ' SER . 0.3 OUTLIER -68.07 153.31 43.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -1.212 . . . . 1.0900000000000001 109.907 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -72.44 137.48 46.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.079 -1.452 . . . . 1.52 107.079 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.7 mtt -115.16 126.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 2.2200000000000002 108.894 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -134.55 133.12 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 1.03 110.848 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.05 157.19 18.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.19 -0.67 . . . . 2.0899999999999999 109.19 179.148 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.49 116.52 7.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.27 -1.011 . . . . 1.0700000000000001 108.27 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.62 131.55 20.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.454 1.436 . . . . 0.87 111.343 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mt -145.67 124.07 6.49 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 1.0900000000000001 110.229 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' CB ' ' CE2' ' A' ' 12' ' ' PHE . 37.3 Cg_exo -51.66 144.37 34.02 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.406 1.404 . . . . 0.95999999999999996 111.673 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.461 ' HG2' HH11 ' A' ' 11' ' ' ARG . 5.5 tpt180 -56.72 -39.93 74.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 2.5899999999999999 109.856 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 14.7 p90 -68.04 -13.58 62.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 0.51000000000000001 109.817 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.32 -10.91 15.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.182 -0.949 . . . . 1.04 110.859 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -56.13 -36.99 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.68 -1.263 . . . . 1.03 109.937 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.99 -20.27 40.96 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.617 -0.993 . . . . 0.17999999999999999 110.617 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 17' ' ' VAL . 4.4 tp -73.56 -42.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.469 . . . . 1.05 109.725 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' N ' ' CG2' ' A' ' 16' ' ' ILE . 92.3 t -70.26 -47.62 65.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.287 -0.883 . . . . 1.05 109.269 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 18' ' ' ILE . 52.8 mt -66.46 -48.21 81.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.588 -0.695 . . . . 1.04 109.863 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.15 162.04 27.85 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.263 -1.535 . . . . 0.16 109.263 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 22' ' ' GLY . 48.3 ttt180 -75.53 136.11 40.6 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.081 -1.246 . . . . 3.3599999999999999 109.124 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.7 m120 60.96 6.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.487 -0.758 . . . . 0.33000000000000002 109.081 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 20' ' ' ARG . . . 80.47 16.48 75.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.52 -1.032 . . . . 0.17000000000000001 110.52 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.46 -35.77 65.86 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.469 -1.606 . . . . 2.3700000000000001 109.508 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.2 mmt -76.09 -58.72 3.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.873 -1.142 . . . . 2.0800000000000001 110.154 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 26' ' ' LYS . 15.1 tt -58.37 -48.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 1.0600000000000001 110.26 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.479 ' N ' ' CG2' ' A' ' 25' ' ' ILE . 54.6 mttt -60.6 -44.99 95.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.999 -1.063 . . . . 1.51 109.513 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.09 -52.64 54.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.249 -0.907 . . . . 2.3500000000000001 109.807 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.17 -40.84 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.053 -1.029 . . . . 1.0700000000000001 108.312 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.7 tt0 -56.18 -46.39 79.38 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.334 -0.946 . . . . 1.5 108.58 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -71.88 -42.08 67.23 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.269 -0.894 . . . . 2.52 109.633 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -67.85 -42.06 81.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.112 -0.992 . . . . 1.74 110.445 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.64 -24.74 14.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 1.0700000000000001 111.553 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . 74.86 54.92 5.59 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 118.842 -1.647 . . . . 0.17999999999999999 109.65 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.83 157.21 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.278 . . . . 1.04 110.432 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -115.04 126.45 54.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.207 -1.034 . . . . 1.0600000000000001 108.207 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.65 123.48 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 1.04 110.676 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -117.4 113.79 22.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.753 -1.203 . . . . 0.25 107.753 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -80.93 140.44 35.29 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.122 -0.987 . . . . 0.23000000000000001 109.576 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' PRO . 9.7 ptmt -126.24 151.47 72.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 2.0499999999999998 109.213 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' LYS . 19.7 Cg_exo -38.22 160.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.205 1.937 . . . . 0.98999999999999999 111.333 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 45.2 p-10 -78.25 103.0 7.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.226 -0.921 . . . . 0.79000000000000004 109.757 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -87.25 122.55 31.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.968 -1.083 . . . . 1.4199999999999999 109.104 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.622 ' C ' ' H ' ' A' ' 45' ' ' THR . . . 123.52 15.43 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.719 -2.152 . . . . 0.47999999999999998 107.719 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 43' ' ' GLY . 4.5 p 60.49 -12.62 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.814 -0.815 . . . . 1.1799999999999999 110.383 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.622 ' H ' ' C ' ' A' ' 43' ' ' GLY . 23.8 p -66.96 145.06 98.84 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.85 -1.156 . . . . 1.0800000000000001 109.768 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.68 49.99 3.09 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.521 2.147 . . . . 1.29 112.826 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -140.31 139.79 35.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.106 . . . . 2.3100000000000001 109.571 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -85.24 139.38 31.69 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.599 1.19 . . . . 2.98 110.73 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -90.59 130.83 39.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.864 -1.162 . . . . 1.05 107.864 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.79 123.5 43.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.033 . . . . 1.05 109.813 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -96.56 107.16 19.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.324 -0.991 . . . . 2.3300000000000001 108.324 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.4 mt -103.52 145.51 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.582 -0.699 . . . . 1.0800000000000001 109.442 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -142.06 151.74 42.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.291 -0.881 . . . . 1.05 109.454 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' PRO . . . 169.7 168.6 31.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.736 -1.746 . . . . 0.25 108.736 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' GLY . 98.0 Cg_exo -40.14 140.62 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 121.756 1.637 . . . . 0.93999999999999995 109.965 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.533 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 78.8 Cg_exo -43.33 -33.09 3.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.269 1.313 . . . . 1.05 112.062 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.91 -55.59 5.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.833 0.825 . . . . 2.0299999999999998 110.175 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -61.93 -30.25 70.77 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.288 -0.565 . . . . 3.27 109.972 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -43.51 97.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.086 -1.009 . . . . 1.0600000000000001 109.283 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 56' ' ' PRO . 1.1 mt-30 -70.01 -55.79 8.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 3.3300000000000001 109.866 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -60.29 -40.96 92.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.42999999999999999 111.396 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.07 99.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.799 -1.188 . . . . 1.03 109.156 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.23 67.34 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.56 -0.713 . . . . 1.03 109.635 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.0 -41.0 87.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 1.8 110.867 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.32 -53.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.719 -1.238 . . . . 1.0700000000000001 109.499 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.35 -43.14 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.545 -0.722 . . . . 1.1200000000000001 110.29 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.1 p -63.11 -49.3 74.96 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.737 -1.227 . . . . 1.0900000000000001 108.596 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -60.37 -37.74 81.69 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.151 -0.968 . . . . 1.9299999999999999 109.083 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.5 tp -71.73 -49.62 37.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 1.3100000000000001 109.096 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.0 tp -55.61 -39.06 70.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 1.1000000000000001 109.453 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -58.33 -35.82 72.47 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.662 -1.236 . . . . 3.6099999999999999 107.662 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -64.17 -21.5 66.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.851 -0.74 . . . . 2.2999999999999998 109.166 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.53 -26.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.371 -0.831 . . . . 1.6699999999999999 109.119 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 . . . . . 0 C--N 1.298 -1.647 0 C-N-CA 120.158 -0.617 . . . . 2.2999999999999998 109.398 179.907 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLY . 56.5 tt0 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.439 -0.948 . . . . 2.3999999999999999 108.439 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.95 131.62 53.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.384 -0.926 . . . . 1.78 110.404 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -146.21 140.36 26.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.511 -0.743 . . . . 1.01 109.07 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.2 m-20 -97.41 138.72 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 2.0 109.442 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -108.84 127.11 53.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.69999999999999996 108.803 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mm -80.88 140.0 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 1.1599999999999999 109.309 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.03 116.75 8.12 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.66 -1.275 . . . . 1.2 110.365 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.96 138.28 56.56 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.014 1.143 . . . . 0.79000000000000004 110.544 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -54.98 -10.39 0.49 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.327 -0.858 . . . . 1.0700000000000001 111.142 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -83.06 -36.11 16.17 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.429 -1.367 . . . . 0.42999999999999999 111.09 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -94.42 -0.37 54.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.463 -1.61 . . . . 2.2599999999999998 111.288 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 116' ' ' GLY . 10.4 t -57.16 -35.23 69.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.898 -1.126 . . . . 1.0800000000000001 111.504 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' N ' HG21 ' A' ' 115' ' ' THR . . . -66.79 -38.69 93.23 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.614 -1.279 . . . . 0.29999999999999999 110.694 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.49 -15.37 59.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.816 -1.403 . . . . 1.1399999999999999 110.893 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.1 mt -84.29 -58.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.517 -1.365 . . . . 1.1299999999999999 110.476 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.469 ' CD1' ' N1 ' ' B' ' 205' ' ' ' DA' . 64.7 mt -58.36 -50.72 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.011 -1.056 . . . . 1.0900000000000001 109.953 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.64 171.14 47.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.806 -1.317 . . . . 0.23999999999999999 109.806 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -64.67 108.58 1.75 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.887 . . . . 2.02 110.647 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.51 11.65 85.28 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.823 -1.18 . . . . 0.31 110.954 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.57 12.63 82.4 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.428 -1.368 . . . . 0.23000000000000001 110.916 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.37 -25.99 17.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.361 -1.67 . . . . 1.9099999999999999 109.271 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.0 m -79.4 -56.46 4.31 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.702 -0.799 . . . . 1.05 110.172 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 20.7 tt -58.51 -36.32 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.071 -1.018 . . . . 1.1100000000000001 110.453 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 128' ' ' SER . 14.9 mtmt -67.15 -55.3 14.76 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.38 -0.928 . . . . 2.1699999999999999 108.718 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 127' ' ' LYS . 51.9 p -47.52 -49.74 25.28 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.158 -1.053 . . . . 0.96999999999999997 108.158 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.453 HG21 HD13 ' A' ' 129' ' ' ILE . 97.6 mt -60.15 -46.87 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.205 -0.934 . . . . 1.05 110.058 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLY . 84.7 p -63.67 -47.05 82.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.682 -1.262 . . . . 0.88 110.846 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -66.3 -50.53 63.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.978 -1.076 . . . . 2.52 110.602 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.56 -39.25 93.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.719 -1.238 . . . . 2.4399999999999999 109.1 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 135' ' ' ALA . 22.6 p -87.23 -6.57 58.53 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.301 -0.874 . . . . 0.89000000000000001 108.723 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' SER . . . 56.73 -0.09 0.19 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.429 -0.794 . . . . 0.23000000000000001 111.265 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 133' ' ' SER . . . -79.19 160.99 26.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.582 -1.54 . . . . 1.05 109.068 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -101.37 115.65 30.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 1.8999999999999999 108.972 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.76 138.43 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.705 -1.247 . . . . 1.0800000000000001 109.098 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -147.54 117.45 7.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.468 -0.938 . . . . 1.8 108.468 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.414 ' CD2' ' CE2' ' A' ' 154' ' ' PHE . 44.9 mt -50.6 120.29 4.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.113 -0.992 . . . . 1.1299999999999999 110.974 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -91.43 120.0 31.89 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.446 -0.946 . . . . 2.7799999999999998 108.446 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -67.21 147.44 53.04 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.153 -0.967 . . . . 3.0099999999999998 109.285 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 142' ' ' ASN . 10.6 p-10 -113.09 118.44 44.28 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 107.871 -1.159 . . . . 2.0800000000000001 107.871 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 147' ' ' ALA . 24.0 Cg_exo -48.58 109.5 0.26 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.601 1.534 . . . . 1.3100000000000001 112.812 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.446 ' N ' ' CD ' ' A' ' 145' ' ' PRO . 23.8 Cg_exo -53.77 -43.64 56.2 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.517 1.478 . . . . 1.22 112.06 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 144' ' ' PRO . 12.5 Cg_exo -54.83 -47.92 24.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.972 1.115 . . . . 1.46 112.904 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -106.91 -40.72 5.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.898 -1.126 . . . . 3.0600000000000001 111.536 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 143' ' ' PRO . . . -67.25 168.93 9.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.793 -1.192 . . . . 1.3 109.333 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -90.92 112.76 55.31 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.39 -0.818 . . . . 1.9299999999999999 109.054 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.94 -15.74 14.3 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.383 1.389 . . . . 1.4099999999999999 110.521 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -78.26 -12.4 60.0 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.024 -0.732 . . . . 2.77 109.024 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.437 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 25.9 mtp -132.21 146.83 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.939 0.876 . . . . 1.9099999999999999 111.211 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -121.75 161.71 22.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.303 -0.999 . . . . 2.0800000000000001 108.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.7 tp -114.56 125.16 53.47 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.451 -0.9 . . . . 1.0800000000000001 110.097 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE2' ' CD2' ' A' ' 139' ' ' LEU . 11.0 m-85 -108.4 122.48 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.478 -0.934 . . . . 0.34000000000000002 108.478 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 43.6 m -89.31 139.64 30.29 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.937 -1.102 . . . . 1.04 109.122 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.2 mt -140.53 122.14 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.897 -1.127 . . . . 1.0800000000000001 108.959 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -137.95 148.0 44.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 3.52 110.369 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' GLN . . . -179.67 -164.06 31.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.444 -2.262 . . . . 0.28000000000000003 107.444 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.496 ' OG1' ' CG ' ' A' ' 162' ' ' GLN . 10.5 p -81.16 150.54 68.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.114 -1.439 . . . . 1.26 107.114 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' THR . 31.6 Cg_exo -37.35 -53.15 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.803 1.668 . . . . 1.0 112.282 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -68.7 -32.72 72.72 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.115 -0.99 . . . . 2.5 110.399 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.496 ' CG ' ' OG1' ' A' ' 159' ' ' THR . 32.9 mm-40 -70.74 -47.27 60.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 2.8799999999999999 110.54 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 164' ' ' ASP . 14.9 tt -63.46 -34.82 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.036 -1.04 . . . . 1.1299999999999999 111.027 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' HG21 ' A' ' 163' ' ' ILE . 0.5 OUTLIER -64.78 -38.14 89.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.8400000000000001 108.872 -179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.18 -41.42 97.13 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.969 -0.692 . . . . 0.93999999999999995 109.475 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.8 -43.96 94.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 1.04 109.633 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -56.5 -41.11 76.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 3.5099999999999998 110.842 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -59.6 -50.49 73.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.103 -0.998 . . . . 1.8400000000000001 110.333 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.71 -50.13 73.67 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.4 -1.32 . . . . 1.0700000000000001 108.632 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 64.7 mt -44.55 -54.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 1.0800000000000001 110.273 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 173' ' ' LYS . 1.3 tt0 -53.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.072 -1.017 . . . . 2.3399999999999999 109.075 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 85.4 mt-10 -34.42 -17.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 1.9399999999999999 113.128 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.676 ' N ' ' O ' ' A' ' 171' ' ' GLU . 12.7 mttt -100.44 -18.9 16.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.84 -1.788 . . . . 2.1400000000000001 109.824 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 171' ' ' GLU . 71.1 mt . . . . . 0 N--CA 1.498 1.925 0 O-C-N 120.689 -1.257 . . . . 1.1499999999999999 108.852 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -1.818 0 O4'-C1'-C2' 108.503 2.184 . . . . 1.1699999999999999 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' ' DA' . . . . . 0.469 ' N1 ' ' CD1' ' A' ' 119' ' ' ILE . . . . . . . . 0 C5'--C4' 1.525 1.812 0 O4'-C1'-C2' 108.529 2.208 . . . . 0.68000000000000005 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' ' DT' . . . . . 0.416 ' O2 ' ' C6 ' ' B' ' 207' ' ' ' DT' . . . . . . . . 0 O4'--C4' 1.423 -2.125 0 O5'-C5'-C4' 113.335 2.239 . . . . 1.1299999999999999 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ' DT' . . . . . 0.416 ' C6 ' ' O2 ' ' B' ' 206' ' ' ' DT' . . . . . . . . 0 P--O5' 1.614 2.099 0 C1'-O4'-C4' 106.381 -2.371 . . . . 1.0700000000000001 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' ' DC' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.529 2.19 0 O5'-C5'-C4' 113.667 2.476 . . . . 0.39000000000000001 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ' DC' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.527 2.01 0 O4'-C4'-C3' 108.167 2.567 . . . . 0.38 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' ' DC' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.529 2.243 0 C4'-C3'-C2' 105.547 2.347 . . . . 1.3600000000000001 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.614 2.148 0 O4'-C4'-C3' 108.127 2.527 . . . . 2.0600000000000001 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' ' DA' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.525 1.791 0 O4'-C1'-C2' 108.543 2.221 . . . . 0.80000000000000004 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.527 1.986 0 O4'-C4'-C3' 107.475 1.875 . . . . 0.37 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -1.879 0 P-O3'-C3' 121.844 1.787 . . . . 0.22 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.063 0 O4'-C1'-C2' 107.819 1.562 . . . . 0.34000000000000002 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.244 0 O5'-C5'-C4' 113.026 2.019 . . . . 0.5 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.526 1.904 0 C4'-C3'-C2' 105.682 2.482 . . . . 0.70999999999999996 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.524 1.669 0 O4'-C4'-C3' 107.648 2.048 . . . . 1.45 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.379 -1.488 . . . . 1.45 109.379 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.07 153.31 43.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -1.212 . . . . 0.49 109.907 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.457 ' CD2' HG23 ' A' ' 5' ' ' ILE . 80.7 t60 -72.44 137.48 46.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.079 -1.452 . . . . 1.09 107.079 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.7 mtt -115.16 126.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 1.63 108.894 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG23 ' CD2' ' A' ' 3' ' ' HIS . 2.1 pt -134.55 133.12 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 0.15 110.848 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.05 157.19 18.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.19 -0.67 . . . . 2.09 109.19 179.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.49 116.52 7.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.27 -1.011 . . . . 0.23 108.27 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.62 131.55 20.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.454 1.436 . . . . 0.56 111.343 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.601 ' CD1' HG21 ' A' ' 17' ' ' VAL . 4.5 mt -145.67 124.07 6.49 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.33 110.229 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' CB ' ' CE2' ' A' ' 12' ' ' PHE . 37.3 Cg_exo -51.66 144.37 34.02 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.406 1.404 . . . . 0.51 111.673 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 11' ' ' ARG . 5.5 tpt180 -56.72 -39.93 74.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 1.91 109.856 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 14.7 p90 -68.04 -13.58 62.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 0.41 109.817 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.543 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -107.32 -10.91 15.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.182 -0.949 . . . . 0.19 110.859 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -56.13 -36.99 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.68 -1.263 . . . . 0.18 109.937 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.99 -20.27 40.96 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.617 -0.993 . . . . 0.18 110.617 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 13' ' ' ALA . 4.4 tp -73.56 -42.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.469 . . . . 0.26 109.725 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.601 HG21 ' CD1' ' A' ' 9' ' ' ILE . 92.3 t -70.26 -47.62 65.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.287 -0.883 . . . . 0.19 109.269 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.767 HD12 ' O2 ' ' B' ' 218' ' ' ' DT' . 52.8 mt -66.46 -48.21 81.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.588 -0.695 . . . . 0.14 109.863 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.15 162.04 27.85 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.263 -1.535 . . . . 0.14 109.263 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -75.53 136.11 40.6 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.081 -1.246 . . . . 2.84 109.124 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.7 m120 60.96 6.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.487 -0.758 . . . . 0.31 109.081 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.47 16.48 75.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.52 -1.032 . . . . 0.17 110.52 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.46 -35.77 65.86 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.469 -1.606 . . . . 2.37 109.508 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.2 mmt -76.09 -58.72 3.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.873 -1.142 . . . . 1.61 110.154 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 26' ' ' LYS . 15.1 tt -58.37 -48.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 0.26 110.26 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.636 ' N ' HG23 ' A' ' 25' ' ' ILE . 54.6 mttt -60.6 -44.99 95.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.999 -1.063 . . . . 0.9 109.513 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.09 -52.64 54.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.249 -0.907 . . . . 1.85 109.807 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.17 -40.84 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.053 -1.029 . . . . 0.29 108.312 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.7 tt0 -56.18 -46.39 79.38 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.334 -0.946 . . . . 0.87 108.58 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -71.88 -42.08 67.23 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.269 -0.894 . . . . 1.94 109.633 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -67.85 -42.06 81.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.112 -0.992 . . . . 1.74 110.445 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.64 -24.74 14.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 0.22 111.553 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . 74.86 54.92 5.59 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 118.842 -1.647 . . . . 0.17 109.65 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.83 157.21 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.278 . . . . 0.15 110.432 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -115.04 126.45 54.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.207 -1.034 . . . . 0.79 108.207 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.65 123.48 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.19 110.676 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -117.4 113.79 22.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.753 -1.203 . . . . 0.23 107.753 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -80.93 140.44 35.29 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.122 -0.987 . . . . 0.2 109.576 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' PRO . 9.7 ptmt -126.24 151.47 72.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 1.45 109.213 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' LYS . 19.7 Cg_exo -38.22 160.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.205 1.937 . . . . 0.56 111.333 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 45.2 p-10 -78.25 103.0 7.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.226 -0.921 . . . . 0.79 109.757 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -87.25 122.55 31.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.968 -1.083 . . . . 1.42 109.104 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.583 ' C ' ' H ' ' A' ' 45' ' ' THR . . . 123.52 15.43 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.719 -2.152 . . . . 0.42 107.719 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 43' ' ' GLY . 4.5 p 60.49 -12.62 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.814 -0.815 . . . . 0.6 110.383 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 43' ' ' GLY . 23.8 p -66.96 145.06 98.84 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.85 -1.156 . . . . 0.5 109.768 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.68 49.99 3.09 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.521 2.147 . . . . 0.82 112.826 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -140.31 139.79 35.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.106 . . . . 2.31 109.571 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -85.24 139.38 31.69 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.599 1.19 . . . . 2.5 110.73 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -90.59 130.83 39.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.864 -1.162 . . . . 0.18 107.864 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.79 123.5 43.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.033 . . . . 0.23 109.813 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -96.56 107.16 19.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.324 -0.991 . . . . 1.83 108.324 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.4 mt -103.52 145.51 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.582 -0.699 . . . . 0.26 109.442 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -142.06 151.74 42.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.291 -0.881 . . . . 0.31 109.454 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' PRO . . . 169.7 168.6 31.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.736 -1.746 . . . . 0.24 108.736 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' GLY . 98.0 Cg_exo -40.14 140.62 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 121.756 1.637 . . . . 0.47 109.965 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.533 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 78.8 Cg_exo -43.33 -33.09 3.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.269 1.313 . . . . 0.7 112.062 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.91 -55.59 5.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.833 0.825 . . . . 2.03 110.175 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -61.93 -30.25 70.77 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.288 -0.565 . . . . 2.79 109.972 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' O ' HD11 ' A' ' 5' ' ' ILE . . . -63.41 -43.51 97.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.086 -1.009 . . . . 0.25 109.283 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 56' ' ' PRO . 1.1 mt-30 -70.01 -55.79 8.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 2.72 109.866 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -60.29 -40.96 92.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.38 111.396 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.07 99.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.799 -1.188 . . . . 0.18 109.156 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' THR . . . -57.23 -33.23 67.34 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.56 -0.713 . . . . 0.18 109.635 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.0 -41.0 87.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 1.8 110.867 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.32 -53.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.719 -1.238 . . . . 0.3 109.499 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.578 HG23 HG22 ' A' ' 17' ' ' VAL . 64.5 mt -62.35 -43.14 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.545 -0.722 . . . . 0.39 110.29 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 63' ' ' ALA . 61.1 p -63.11 -49.3 74.96 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.737 -1.227 . . . . 0.42 108.596 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -60.37 -37.74 81.69 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.151 -0.968 . . . . 1.93 109.083 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.5 tp -71.73 -49.62 37.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 0.76 109.096 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.0 tp -55.61 -39.06 70.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 0.35 109.453 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -58.33 -35.82 72.47 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.662 -1.236 . . . . 3.09 107.662 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -64.17 -21.5 66.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.851 -0.74 . . . . 1.96 109.166 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.53 -26.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.371 -0.831 . . . . 1.24 109.119 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 . . . . . 0 C--N 1.298 -1.647 0 C-N-CA 120.158 -0.617 . . . . 1.94 109.398 179.907 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLY . 56.5 tt0 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.439 -0.948 . . . . 1.9 108.439 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.95 131.62 53.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.384 -0.926 . . . . 1.78 110.404 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -146.21 140.36 26.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.511 -0.743 . . . . 0.87 109.07 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 107' ' ' ASN . 1.2 m-20 -97.41 138.72 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 1.27 109.442 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -108.84 127.11 53.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.5 108.803 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mm -80.88 140.0 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 0.47 109.309 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.03 116.75 8.12 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.66 -1.275 . . . . 0.61 110.365 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.96 138.28 56.56 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.014 1.143 . . . . 0.55 110.544 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -54.98 -10.39 0.49 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.327 -0.858 . . . . 0.41 111.142 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -83.06 -36.11 16.17 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.429 -1.367 . . . . 0.35 111.09 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -94.42 -0.37 54.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.463 -1.61 . . . . 1.74 111.288 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.4 t -57.16 -35.23 69.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.898 -1.126 . . . . 0.33 111.504 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.79 -38.69 93.23 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.614 -1.279 . . . . 0.3 110.694 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.49 -15.37 59.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.816 -1.403 . . . . 0.47 110.893 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.1 mt -84.29 -58.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.517 -1.365 . . . . 0.44 110.476 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.939 HD12 ' N1 ' ' B' ' 205' ' ' ' DA' . 64.7 mt -58.36 -50.72 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.011 -1.056 . . . . 0.26 109.953 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.64 171.14 47.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.806 -1.317 . . . . 0.22 109.806 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -64.67 108.58 1.75 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.887 . . . . 1.44 110.647 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.51 11.65 85.28 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.823 -1.18 . . . . 0.27 110.954 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.57 12.63 82.4 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.428 -1.368 . . . . 0.22 110.916 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.37 -25.99 17.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.361 -1.67 . . . . 1.91 109.271 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.0 m -79.4 -56.46 4.31 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.702 -0.799 . . . . 0.23 110.172 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 20.7 tt -58.51 -36.32 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.071 -1.018 . . . . 0.37 110.453 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 128' ' ' SER . 14.9 mtmt -67.15 -55.3 14.76 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.38 -0.928 . . . . 1.64 108.718 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 127' ' ' LYS . 51.9 p -47.52 -49.74 25.28 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.158 -1.053 . . . . 0.26 108.158 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.15 -46.87 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.205 -0.934 . . . . 0.18 110.058 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLY . 84.7 p -63.67 -47.05 82.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.682 -1.262 . . . . 0.19 110.846 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -66.3 -50.53 63.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.978 -1.076 . . . . 1.95 110.602 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.56 -39.25 93.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.719 -1.238 . . . . 1.89 109.1 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.482 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 22.6 p -87.23 -6.57 58.53 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.301 -0.874 . . . . 0.23 108.723 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' SER . . . 56.73 -0.09 0.19 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.429 -0.794 . . . . 0.21 111.265 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 133' ' ' SER . . . -79.19 160.99 26.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.582 -1.54 . . . . 0.19 109.068 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -101.37 115.65 30.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 1.4 108.972 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.76 138.43 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.705 -1.247 . . . . 0.23 109.098 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -147.54 117.45 7.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.468 -0.938 . . . . 1.8 108.468 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.414 ' CD2' ' CE2' ' A' ' 154' ' ' PHE . 44.9 mt -50.6 120.29 4.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.113 -0.992 . . . . 0.41 110.974 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.404 ' HG2' HD23 ' A' ' 153' ' ' LEU . 39.9 tp60 -91.43 120.0 31.89 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.446 -0.946 . . . . 2.16 108.446 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -67.21 147.44 53.04 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.153 -0.967 . . . . 2.52 109.285 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 142' ' ' ASN . 10.6 p-10 -113.09 118.44 44.28 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 107.871 -1.159 . . . . 2.08 107.871 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 147' ' ' ALA . 24.0 Cg_exo -48.58 109.5 0.26 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.601 1.534 . . . . 0.96 112.812 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.446 ' N ' ' CD ' ' A' ' 145' ' ' PRO . 23.8 Cg_exo -53.77 -43.64 56.2 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.517 1.478 . . . . 1.07 112.06 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 144' ' ' PRO . 12.5 Cg_exo -54.83 -47.92 24.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.972 1.115 . . . . 1.2 112.904 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -106.91 -40.72 5.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.898 -1.126 . . . . 2.46 111.536 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 143' ' ' PRO . . . -67.25 168.93 9.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.793 -1.192 . . . . 0.77 109.333 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -90.92 112.76 55.31 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.39 -0.818 . . . . 1.93 109.054 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.94 -15.74 14.3 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.383 1.389 . . . . 1.05 110.521 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -78.26 -12.4 60.0 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.024 -0.732 . . . . 2.16 109.024 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.437 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 25.9 mtp -132.21 146.83 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.939 0.876 . . . . 1.68 111.211 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -121.75 161.71 22.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.303 -0.999 . . . . 1.53 108.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.404 HD23 ' HG2' ' A' ' 140' ' ' GLN . 32.7 tp -114.56 125.16 53.47 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.451 -0.9 . . . . 0.29 110.097 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE2' ' CD2' ' A' ' 139' ' ' LEU . 11.0 m-85 -108.4 122.48 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.478 -0.934 . . . . 0.26 108.478 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 43.6 m -89.31 139.64 30.29 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.937 -1.102 . . . . 0.35 109.122 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.2 mt -140.53 122.14 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.897 -1.127 . . . . 0.3 108.959 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -137.95 148.0 44.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 3.0 110.369 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' GLN . . . -179.67 -164.06 31.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.444 -2.262 . . . . 0.27 107.444 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.496 ' OG1' ' CG ' ' A' ' 162' ' ' GLN . 10.5 p -81.16 150.54 68.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.114 -1.439 . . . . 0.57 107.114 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' THR . 31.6 Cg_exo -37.35 -53.15 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.803 1.668 . . . . 0.6 112.282 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -68.7 -32.72 72.72 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.115 -0.99 . . . . 1.93 110.399 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.496 ' CG ' ' OG1' ' A' ' 159' ' ' THR . 32.9 mm-40 -70.74 -47.27 60.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 2.14 110.54 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.9 tt -63.46 -34.82 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.036 -1.04 . . . . 0.42 111.027 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -38.14 89.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.84 108.872 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.18 -41.42 97.13 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.969 -0.692 . . . . 0.32 109.475 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.8 -43.96 94.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 0.19 109.633 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -56.5 -41.11 76.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 2.94 110.842 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -59.6 -50.49 73.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.103 -0.998 . . . . 1.84 110.333 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.71 -50.13 73.67 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.4 -1.32 . . . . 0.26 108.632 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 64.7 mt -44.55 -54.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.28 110.273 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 173' ' ' LYS . 1.3 tt0 -53.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.072 -1.017 . . . . 2.34 109.075 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 85.4 mt-10 -34.42 -17.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 1.94 113.128 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.676 ' N ' ' O ' ' A' ' 171' ' ' GLU . 12.7 mttt -100.44 -18.9 16.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.84 -1.788 . . . . 1.6 109.824 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 171' ' ' GLU . 71.1 mt . . . . . 0 N--CA 1.498 1.925 0 O-C-N 120.689 -1.257 . . . . 1.15 108.852 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -1.818 0 O4'-C1'-C2' 108.503 2.184 . . . . 0.61 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 205' ' ' ' DA' . . . . . 0.939 ' N1 ' HD12 ' A' ' 119' ' ' ILE . . . . . . . . 0 C5'--C4' 1.525 1.812 0 O4'-C1'-C2' 108.529 2.208 . . . . 0.68 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' ' DT' . . . . . 0.416 ' O2 ' ' C6 ' ' B' ' 207' ' ' ' DT' . . . . . . . . 0 O4'--C4' 1.423 -2.125 0 O5'-C5'-C4' 113.335 2.239 . . . . 0.47 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ' DT' . . . . . 0.416 ' C6 ' ' O2 ' ' B' ' 206' ' ' ' DT' . . . . . . . . 0 P--O5' 1.614 2.099 0 C1'-O4'-C4' 106.381 -2.371 . . . . 0.39 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' ' DC' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.529 2.19 0 O5'-C5'-C4' 113.667 2.476 . . . . 0.39 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ' DC' . . . . . 0.408 H2'' ' C6 ' ' B' ' 210' ' ' ' DC' . . . . . . . . 0 C5'--C4' 1.527 2.01 0 O4'-C4'-C3' 108.167 2.567 . . . . 0.36 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' ' DC' . . . . . 0.408 ' C6 ' H2'' ' B' ' 209' ' ' ' DC' . . . . . . . . 0 C5'--C4' 1.529 2.243 0 C4'-C3'-C2' 105.547 2.347 . . . . 1.2 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.614 2.148 0 O4'-C4'-C3' 108.127 2.527 . . . . 2.05 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 216' ' ' ' DA' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.525 1.791 0 O4'-C1'-C2' 108.543 2.221 . . . . 0.62 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.527 1.986 0 O4'-C4'-C3' 107.475 1.875 . . . . 0.37 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ' DT' . . . . . 0.767 ' O2 ' HD12 ' A' ' 18' ' ' ILE . . . . . . . . 0 O4'--C4' 1.425 -1.879 0 P-O3'-C3' 121.844 1.787 . . . . 0.22 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ' DT' . . . . . 0.421 ' C2 ' HD13 ' A' ' 18' ' ' ILE . . . . . . . . 0 O4'--C4' 1.423 -2.063 0 O4'-C1'-C2' 107.819 1.562 . . . . 0.34 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.244 0 O5'-C5'-C4' 113.026 2.019 . . . . 0.5 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.526 1.904 0 C4'-C3'-C2' 105.682 2.482 . . . . 0.68 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.524 1.669 0 O4'-C4'-C3' 107.648 2.048 . . . . 1.41 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.379 -1.488 . . . . 1.45 109.379 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.07 153.31 43.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -1.212 . . . . 0.49 109.907 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.457 ' CD2' HG23 ' A' ' 5' ' ' ILE . 80.7 t60 -72.44 137.48 46.47 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.079 -1.452 . . . . 1.09 107.079 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.7 mtt -115.16 126.24 54.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 1.63 108.894 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG23 ' CD2' ' A' ' 3' ' ' HIS . 2.1 pt -134.55 133.12 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 0.15 110.848 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.05 157.19 18.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.19 -0.67 . . . . 2.09 109.19 179.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.49 116.52 7.74 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.27 -1.011 . . . . 0.23 108.27 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.62 131.55 20.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.454 1.436 . . . . 0.56 111.343 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.601 ' CD1' HG21 ' A' ' 17' ' ' VAL . 4.5 mt -145.67 124.07 6.49 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.33 110.229 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' CB ' ' CE2' ' A' ' 12' ' ' PHE . 37.3 Cg_exo -51.66 144.37 34.02 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.406 1.404 . . . . 0.51 111.673 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 11' ' ' ARG . 5.5 tpt180 -56.72 -39.93 74.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 1.91 109.856 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 14.7 p90 -68.04 -13.58 62.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 0.41 109.817 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.543 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -107.32 -10.91 15.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.182 -0.949 . . . . 0.19 110.859 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -56.13 -36.99 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.68 -1.263 . . . . 0.18 109.937 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.99 -20.27 40.96 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.617 -0.993 . . . . 0.18 110.617 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 13' ' ' ALA . 4.4 tp -73.56 -42.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.469 . . . . 0.26 109.725 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.601 HG21 ' CD1' ' A' ' 9' ' ' ILE . 92.3 t -70.26 -47.62 65.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.287 -0.883 . . . . 0.19 109.269 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.767 HD12 ' O2 ' ' B' ' 218' ' ' ' DT' . 52.8 mt -66.46 -48.21 81.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.588 -0.695 . . . . 0.14 109.863 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.15 162.04 27.85 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.263 -1.535 . . . . 0.14 109.263 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -75.53 136.11 40.6 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.081 -1.246 . . . . 2.84 109.124 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.7 m120 60.96 6.96 1.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.487 -0.758 . . . . 0.31 109.081 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.47 16.48 75.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.52 -1.032 . . . . 0.17 110.52 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.46 -35.77 65.86 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.469 -1.606 . . . . 2.37 109.508 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.2 mmt -76.09 -58.72 3.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.873 -1.142 . . . . 1.61 110.154 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 26' ' ' LYS . 15.1 tt -58.37 -48.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.89 . . . . 0.26 110.26 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.636 ' N ' HG23 ' A' ' 25' ' ' ILE . 54.6 mttt -60.6 -44.99 95.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.999 -1.063 . . . . 0.9 109.513 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.09 -52.64 54.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.249 -0.907 . . . . 1.85 109.807 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.17 -40.84 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.053 -1.029 . . . . 0.29 108.312 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.7 tt0 -56.18 -46.39 79.38 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.334 -0.946 . . . . 0.87 108.58 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -71.88 -42.08 67.23 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.269 -0.894 . . . . 1.94 109.633 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -67.85 -42.06 81.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.112 -0.992 . . . . 1.74 110.445 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.64 -24.74 14.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 0.22 111.553 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . 74.86 54.92 5.59 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 118.842 -1.647 . . . . 0.17 109.65 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.83 157.21 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.278 . . . . 0.15 110.432 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -115.04 126.45 54.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.207 -1.034 . . . . 0.79 108.207 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.65 123.48 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.19 110.676 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -117.4 113.79 22.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.753 -1.203 . . . . 0.23 107.753 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -80.93 140.44 35.29 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.122 -0.987 . . . . 0.2 109.576 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' PRO . 9.7 ptmt -126.24 151.47 72.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 1.45 109.213 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' LYS . 19.7 Cg_exo -38.22 160.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.205 1.937 . . . . 0.56 111.333 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 45.2 p-10 -78.25 103.0 7.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.226 -0.921 . . . . 0.79 109.757 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -87.25 122.55 31.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.968 -1.083 . . . . 1.42 109.104 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.583 ' C ' ' H ' ' A' ' 45' ' ' THR . . . 123.52 15.43 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.719 -2.152 . . . . 0.42 107.719 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 43' ' ' GLY . 4.5 p 60.49 -12.62 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.814 -0.815 . . . . 0.6 110.383 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 43' ' ' GLY . 23.8 p -66.96 145.06 98.84 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.85 -1.156 . . . . 0.5 109.768 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.68 49.99 3.09 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.521 2.147 . . . . 0.82 112.826 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -140.31 139.79 35.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.93 -1.106 . . . . 2.31 109.571 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -85.24 139.38 31.69 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.599 1.19 . . . . 2.5 110.73 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -90.59 130.83 39.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.864 -1.162 . . . . 0.18 107.864 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.79 123.5 43.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.033 . . . . 0.23 109.813 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -96.56 107.16 19.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.324 -0.991 . . . . 1.83 108.324 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.4 mt -103.52 145.51 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.582 -0.699 . . . . 0.26 109.442 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -142.06 151.74 42.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.291 -0.881 . . . . 0.31 109.454 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' PRO . . . 169.7 168.6 31.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.736 -1.746 . . . . 0.24 108.736 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' GLY . 98.0 Cg_exo -40.14 140.62 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 121.756 1.637 . . . . 0.47 109.965 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.533 ' O ' ' CG ' ' A' ' 60' ' ' GLN . 78.8 Cg_exo -43.33 -33.09 3.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.269 1.313 . . . . 0.7 112.062 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.91 -55.59 5.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.833 0.825 . . . . 2.03 110.175 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -61.93 -30.25 70.77 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.288 -0.565 . . . . 2.79 109.972 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' O ' HD11 ' A' ' 5' ' ' ILE . . . -63.41 -43.51 97.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.086 -1.009 . . . . 0.25 109.283 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 56' ' ' PRO . 1.1 mt-30 -70.01 -55.79 8.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 2.72 109.866 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -60.29 -40.96 92.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.38 111.396 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.07 99.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.799 -1.188 . . . . 0.18 109.156 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' THR . . . -57.23 -33.23 67.34 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.56 -0.713 . . . . 0.18 109.635 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.0 -41.0 87.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -0.839 . . . . 1.8 110.867 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.32 -53.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.719 -1.238 . . . . 0.3 109.499 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.578 HG23 HG22 ' A' ' 17' ' ' VAL . 64.5 mt -62.35 -43.14 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.545 -0.722 . . . . 0.39 110.29 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 63' ' ' ALA . 61.1 p -63.11 -49.3 74.96 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.737 -1.227 . . . . 0.42 108.596 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -60.37 -37.74 81.69 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.151 -0.968 . . . . 1.93 109.083 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.5 tp -71.73 -49.62 37.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.319 -0.863 . . . . 0.76 109.096 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.0 tp -55.61 -39.06 70.29 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 0.35 109.453 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -58.33 -35.82 72.47 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.662 -1.236 . . . . 3.09 107.662 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -64.17 -21.5 66.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.851 -0.74 . . . . 1.96 109.166 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.53 -26.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.371 -0.831 . . . . 1.24 109.119 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 . . . . . 0 C--N 1.298 -1.647 0 C-N-CA 120.158 -0.617 . . . . 1.94 109.398 179.907 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLY . 56.5 tt0 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.439 -0.948 . . . . 1.9 108.439 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.95 131.62 53.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.384 -0.926 . . . . 1.78 110.404 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -146.21 140.36 26.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.511 -0.743 . . . . 0.87 109.07 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 107' ' ' ASN . 1.2 m-20 -97.41 138.72 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 1.27 109.442 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -108.84 127.11 53.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.5 108.803 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.3 mm -80.88 140.0 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 0.47 109.309 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.03 116.75 8.12 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.66 -1.275 . . . . 0.61 110.365 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.96 138.28 56.56 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.014 1.143 . . . . 0.55 110.544 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -54.98 -10.39 0.49 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.327 -0.858 . . . . 0.41 111.142 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -83.06 -36.11 16.17 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.429 -1.367 . . . . 0.35 111.09 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -94.42 -0.37 54.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.463 -1.61 . . . . 1.74 111.288 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.4 t -57.16 -35.23 69.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.898 -1.126 . . . . 0.33 111.504 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.79 -38.69 93.23 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.614 -1.279 . . . . 0.3 110.694 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.49 -15.37 59.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.816 -1.403 . . . . 0.47 110.893 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.1 mt -84.29 -58.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.517 -1.365 . . . . 0.44 110.476 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.939 HD12 ' N1 ' ' B' ' 205' ' ' ' DA' . 64.7 mt -58.36 -50.72 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.011 -1.056 . . . . 0.26 109.953 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.64 171.14 47.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.806 -1.317 . . . . 0.22 109.806 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -64.67 108.58 1.75 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.887 . . . . 1.44 110.647 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.51 11.65 85.28 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.823 -1.18 . . . . 0.27 110.954 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.57 12.63 82.4 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.428 -1.368 . . . . 0.22 110.916 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -53.37 -25.99 17.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.361 -1.67 . . . . 1.91 109.271 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.0 m -79.4 -56.46 4.31 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.702 -0.799 . . . . 0.23 110.172 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 20.7 tt -58.51 -36.32 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.071 -1.018 . . . . 0.37 110.453 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 128' ' ' SER . 14.9 mtmt -67.15 -55.3 14.76 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.38 -0.928 . . . . 1.64 108.718 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 127' ' ' LYS . 51.9 p -47.52 -49.74 25.28 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.158 -1.053 . . . . 0.26 108.158 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.15 -46.87 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.205 -0.934 . . . . 0.18 110.058 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLY . 84.7 p -63.67 -47.05 82.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.682 -1.262 . . . . 0.19 110.846 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -66.3 -50.53 63.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.978 -1.076 . . . . 1.95 110.602 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.56 -39.25 93.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.719 -1.238 . . . . 1.89 109.1 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.482 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 22.6 p -87.23 -6.57 58.53 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.301 -0.874 . . . . 0.23 108.723 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' SER . . . 56.73 -0.09 0.19 Allowed Glycine 0 N--CA 1.494 2.517 0 O-C-N 121.429 -0.794 . . . . 0.21 111.265 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 133' ' ' SER . . . -79.19 160.99 26.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.582 -1.54 . . . . 0.19 109.068 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -101.37 115.65 30.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 1.4 108.972 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.76 138.43 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.705 -1.247 . . . . 0.23 109.098 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -147.54 117.45 7.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.468 -0.938 . . . . 1.8 108.468 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.414 ' CD2' ' CE2' ' A' ' 154' ' ' PHE . 44.9 mt -50.6 120.29 4.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.113 -0.992 . . . . 0.41 110.974 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.404 ' HG2' HD23 ' A' ' 153' ' ' LEU . 39.9 tp60 -91.43 120.0 31.89 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.446 -0.946 . . . . 2.16 108.446 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -67.21 147.44 53.04 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.153 -0.967 . . . . 2.52 109.285 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 142' ' ' ASN . 10.6 p-10 -113.09 118.44 44.28 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 107.871 -1.159 . . . . 2.08 107.871 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 147' ' ' ALA . 24.0 Cg_exo -48.58 109.5 0.26 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.601 1.534 . . . . 0.96 112.812 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.446 ' N ' ' CD ' ' A' ' 145' ' ' PRO . 23.8 Cg_exo -53.77 -43.64 56.2 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.517 1.478 . . . . 1.07 112.06 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 144' ' ' PRO . 12.5 Cg_exo -54.83 -47.92 24.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.972 1.115 . . . . 1.2 112.904 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -106.91 -40.72 5.4 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.898 -1.126 . . . . 2.46 111.536 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 143' ' ' PRO . . . -67.25 168.93 9.56 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.793 -1.192 . . . . 0.77 109.333 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -90.92 112.76 55.31 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.39 -0.818 . . . . 1.93 109.054 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.94 -15.74 14.3 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.383 1.389 . . . . 1.05 110.521 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -78.26 -12.4 60.0 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.024 -0.732 . . . . 2.16 109.024 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.437 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 25.9 mtp -132.21 146.83 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.939 0.876 . . . . 1.68 111.211 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -121.75 161.71 22.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.303 -0.999 . . . . 1.53 108.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.404 HD23 ' HG2' ' A' ' 140' ' ' GLN . 32.7 tp -114.56 125.16 53.47 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.451 -0.9 . . . . 0.29 110.097 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE2' ' CD2' ' A' ' 139' ' ' LEU . 11.0 m-85 -108.4 122.48 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.478 -0.934 . . . . 0.26 108.478 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 43.6 m -89.31 139.64 30.29 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.937 -1.102 . . . . 0.35 109.122 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.2 mt -140.53 122.14 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.897 -1.127 . . . . 0.3 108.959 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -137.95 148.0 44.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 3.0 110.369 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' GLN . . . -179.67 -164.06 31.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.444 -2.262 . . . . 0.27 107.444 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.496 ' OG1' ' CG ' ' A' ' 162' ' ' GLN . 10.5 p -81.16 150.54 68.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.114 -1.439 . . . . 0.57 107.114 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' THR . 31.6 Cg_exo -37.35 -53.15 1.39 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.803 1.668 . . . . 0.6 112.282 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -68.7 -32.72 72.72 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.115 -0.99 . . . . 1.93 110.399 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.496 ' CG ' ' OG1' ' A' ' 159' ' ' THR . 32.9 mm-40 -70.74 -47.27 60.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 2.14 110.54 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.9 tt -63.46 -34.82 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.036 -1.04 . . . . 0.42 111.027 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -38.14 89.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.84 108.872 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.18 -41.42 97.13 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.969 -0.692 . . . . 0.32 109.475 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.8 -43.96 94.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 0.19 109.633 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -56.5 -41.11 76.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 2.94 110.842 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -59.6 -50.49 73.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.103 -0.998 . . . . 1.84 110.333 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.71 -50.13 73.67 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.4 -1.32 . . . . 0.26 108.632 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 64.7 mt -44.55 -54.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.28 110.273 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 173' ' ' LYS . 1.3 tt0 -53.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.072 -1.017 . . . . 2.34 109.075 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 85.4 mt-10 -34.42 -17.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 1.94 113.128 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.676 ' N ' ' O ' ' A' ' 171' ' ' GLU . 12.7 mttt -100.44 -18.9 16.49 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.84 -1.788 . . . . 1.6 109.824 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 171' ' ' GLU . 71.1 mt . . . . . 0 N--CA 1.498 1.925 0 O-C-N 120.689 -1.257 . . . . 1.15 108.852 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -1.818 0 O4'-C1'-C2' 108.503 2.184 . . . . 0.61 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' ' DA' . . . . . 0.939 ' N1 ' HD12 ' A' ' 119' ' ' ILE . . . . . . . . 0 C5'--C4' 1.525 1.812 0 O4'-C1'-C2' 108.529 2.208 . . . . 0.68 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' ' DT' . . . . . 0.416 ' O2 ' ' C6 ' ' B' ' 207' ' ' ' DT' . . . . . . . . 0 O4'--C4' 1.423 -2.125 0 O5'-C5'-C4' 113.335 2.239 . . . . 0.47 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ' DT' . . . . . 0.416 ' C6 ' ' O2 ' ' B' ' 206' ' ' ' DT' . . . . . . . . 0 P--O5' 1.614 2.099 0 C1'-O4'-C4' 106.381 -2.371 . . . . 0.39 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' ' DC' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.529 2.19 0 O5'-C5'-C4' 113.667 2.476 . . . . 0.39 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ' DC' . . . . . 0.408 H2'' ' C6 ' ' B' ' 210' ' ' ' DC' . . . . . . . . 0 C5'--C4' 1.527 2.01 0 O4'-C4'-C3' 108.167 2.567 . . . . 0.36 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' ' DC' . . . . . 0.408 ' C6 ' H2'' ' B' ' 209' ' ' ' DC' . . . . . . . . 0 C5'--C4' 1.529 2.243 0 C4'-C3'-C2' 105.547 2.347 . . . . 1.2 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.614 2.148 0 O4'-C4'-C3' 108.127 2.527 . . . . 2.05 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' ' DA' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.525 1.791 0 O4'-C1'-C2' 108.543 2.221 . . . . 0.62 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.527 1.986 0 O4'-C4'-C3' 107.475 1.875 . . . . 0.37 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ' DT' . . . . . 0.767 ' O2 ' HD12 ' A' ' 18' ' ' ILE . . . . . . . . 0 O4'--C4' 1.425 -1.879 0 P-O3'-C3' 121.844 1.787 . . . . 0.22 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ' DT' . . . . . 0.421 ' C2 ' HD13 ' A' ' 18' ' ' ILE . . . . . . . . 0 O4'--C4' 1.423 -2.063 0 O4'-C1'-C2' 107.819 1.562 . . . . 0.34 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.244 0 O5'-C5'-C4' 113.026 2.019 . . . . 0.5 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.526 1.904 0 C4'-C3'-C2' 105.682 2.482 . . . . 0.68 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ' DT' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.524 1.669 0 O4'-C4'-C3' 107.648 2.048 . . . . 1.41 . . . . . . . . . . 0 0 . 1 stop_ save_